Protein Fluidics is commercializing biological assay automation platforms using our novel microfluidic technologies to accelerate data driven decisions. The Pu·MA System 3D for your 3D cell models, organoids or spheroids, maintains the cells in our specially designed flowchips to allow for easy media, metabolite or reagent exchanges for your oncology, toxicity or metabolomics research. At the core of the Pu·MA System is our patented Valve-less Fluidic Switching (VLFS) which enables precision transfer of reagents through flowchips without the use of integrated valves or pumps. We are passionate about providing scientists with the latest technologies to help them create the next generation of therapeutic and diagnostic tests. The company is privately held and located in the San Francisco Bay Area.